id | C00003820 |
---|---|
Name | Acacetin / Apigenin 4'-methyl ether / 5,7-Dihydroxy-4'-methoxyflavone |
CAS RN | 480-44-4 |
Standard InChI | InChI=1S/C16H12O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-8,17-18H,1H3 |
Standard InChI (Main Layer) | InChI=1S/C16H12O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-8,17-18H,1H3 |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 3 |
By standard InChI | CHEMBL243664 |
---|---|
By standard InChI Main Layer | CHEMBL243664 |
By LinkDB | C01470 |
---|
By CAS RN | C023717 |
---|
class name | count |
---|---|
asterids | 19 |
rosids | 4 |
Spermatophyta | 1 |
Liliopsida | 1 |
family name | count |
---|---|
Lamiaceae | 9 |
Asteraceae | 6 |
Fabaceae | 2 |
Caprifoliaceae | 2 |
Podocarpaceae | 1 |
Betulaceae | 1 |
Stilbaceae | 1 |
Plantaginaceae | 1 |
Xanthorrhoeaceae | 1 |
Biebersteiniaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL243664 |
CHEMBL1614110
(1)
CHEMBL1741321
(1)
|
1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL243664 |
CHEMBL1613992
(1)
CHEMBL1613995
(1)
|
7 / 44 |
P49336 | Cyclin-dependent kinase 8 | Cdk8 | CHEMBL243664 |
CHEMBL1963824
(1)
|
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL243664 |
CHEMBL1613842
(2)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL243664 |
CHEMBL2114784
(2)
|
1 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL243664 |
CHEMBL2341203
(1)
CHEMBL2341207
(1)
|
0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL243664 |
CHEMBL1614331
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL243664 |
CHEMBL1614544
(1)
|
11 / 10 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | CHEMBL243664 |
CHEMBL926267
(1)
CHEMBL1225717
(1)
CHEMBL1780345 (1) CHEMBL1780377 (1) CHEMBL1780378 (1) CHEMBL1780379 (1) CHEMBL1780380 (1) CHEMBL1780381 (1) CHEMBL1780385 (1) |
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL243664 |
CHEMBL1614027
(1)
CHEMBL1741325
(1)
|
0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL243664 |
CHEMBL941404
(1)
|
1 / 11 |
Q9Y3R4 | Sialidase-2 | Enzyme | CHEMBL243664 |
CHEMBL1100507
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL243664 |
CHEMBL1614458
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL243664 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL243664 |
CHEMBL1794584
(1)
|
2 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | CHEMBL243664 |
CHEMBL1613838
(1)
|
0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL243664 |
CHEMBL2114807
(1)
|
4 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL243664 |
CHEMBL1052488
(1)
CHEMBL1052489
(1)
|
0 / 1 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL243664 |
CHEMBL1059360
(1)
CHEMBL1059361
(1)
|
5 / 3 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | CHEMBL243664 |
CHEMBL926266
(1)
CHEMBL1225718
(1)
CHEMBL1780346 (1) CHEMBL1780382 (1) CHEMBL1780383 (1) |
4 / 4 |
P04745 | Alpha-amylase 1 | Enzyme | CHEMBL243664 |
CHEMBL964479
(2)
|
0 / 0 |
P50750 | Cyclin-dependent kinase 9 | Cdk9 | CHEMBL243664 |
CHEMBL1963831
(1)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL243664 |
CHEMBL1613808
(1)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL243664 |
CHEMBL926268
(1)
CHEMBL1225716
(1)
CHEMBL1741322 (1) |
0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | CHEMBL243664 |
CHEMBL2076243
(1)
CHEMBL2078552
(1)
|
2 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | CHEMBL243664 |
CHEMBL1614342
(1)
|
1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL243664 |
CHEMBL1738588
(1)
CHEMBL1738317
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL243664 |
CHEMBL1613777
(1)
CHEMBL1741323
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL243664 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
CHEMBL1741324 (1) |
0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL243664 |
CHEMBL1794483
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL243664 |
CHEMBL1614250
(2)
CHEMBL1614421
(2)
CHEMBL1614502 (1) |
4 / 3 |
P10275 | Androgen receptor | NR3C4 | CHEMBL243664 |
CHEMBL1052486
(1)
|
3 / 4 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | CHEMBL243664 |
CHEMBL1059364
(1)
CHEMBL1059365
(1)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL243664 |
CHEMBL1614364
(1)
|
1 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL243664 |
CHEMBL1614257
(3)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL243664 |
CHEMBL1614257
(3)
|
1 / 3 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | CHEMBL243664 |
CHEMBL2354287
(1)
|
1 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C023717 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | acacetin results in decreased activity of CYP1A1 protein |
decreases activity
|
protein |
21053930
21482471 |
C023717 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | CYP1A1 protein results in increased metabolism of acacetin |
increases metabolic processing
|
protein |
21482471
|
C023717 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | acacetin results in decreased activity of CYP1A2 protein |
decreases activity
|
protein |
21053930
|
C023717 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | acacetin binds to and results in decreased activity of CYP1B1 protein |
affects binding
/ decreases activity |
protein |
21053930
|
C023717 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | CYP1B1 protein results in increased metabolism of acacetin |
increases metabolic processing
|
protein |
21482471
|
C023717 | 1559 |
CYP2C9
CPC9 CYP2C CYP2C10 CYPIIC9 P450IIC9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | acacetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] |
decreases reaction
/ increases hydroxylation |
protein |
21053930
|
C023717 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | acacetin binds to and results in decreased activity of CYP3A4 protein |
affects binding
/ decreases activity |
protein |
21053930
|
C023717 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | acacetin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam] |
decreases reaction
/ increases chemical synthesis / increases oxidation |
protein |
21053930
|
C023717 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | acacetin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam] |
increases chemical synthesis
/ increases oxidation / increases reaction |
protein |
21053930
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P00533
P04637 |
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P37231
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) |
H00018 | Gastric cancer |
P00533
(related)
P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
|
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |